Customer Services

The Molecular Diagnostics Market DNA Probes And Biochips: A 7-Country Market Survey

Product Code VEP00089
Publication Date January 2008
Publisher Venture Planning Grp.
Product Type Report
Pages 1050
Buy this product or for assistance call +44 20 7060 7474
PDF £18,160.00$27497 | €20268
PRINT £15,125.00$22901 | €16881
FAX Order above formats by FAX

The "Molecular Diagnostics Market" report is design to assist diagnostics industry executives in evaluating emerging opportunities and developing effective business, R&D and marketing strategies for this dynamic and evolving market segment. This two-volume, 1050-page report contains 96 tables and presents Worldwide Market Overview; Market Segmentation Analysis; Product/Technology Review; Competitive Assessments; as well as Opportunities and Strategic Recommendations.

  • I. Introduction
  • II. Worldwide Market and Technology Overview
    • A. Dna Sequencing
      • 1. Introduction
      • 2. Sequencing Methods
      • 3. Autoradiography
      • 4. The Human Genome Project
      • 5. Sequencing Automation
      • 6. Image Scanners
      • 7. Fluorescent Detection
      • 8. Gene Profiling
      • 9. Gene Expression
      • 10. Polymorphism Screening
      • 11. Protein Interaction Networks
    • B. Dna and Rna Probe Technology
      • 1. Basic Principles
      • 2. Probe Preparation
      • 3. The Dna Probe Test
        • a. Sample Preparation
        • b. Hybridization
        • c. Separation
        • d. Detection/Measurement
      • 4. Test Formats
        • a. Filter Hybridization
        • b. Southern Blot
        • c. Northern Blot
        • d. in Situ Hybridization
        • e. Others
      • 5. Labeling Techniques
      • 6. Amplification Methods
        • * Pcr
          • - Temperature Cyclers
          • - Pcr Variations
        • * Immuno-Pcr
        • * Qc-Pcr
        • * Dap-Pcr
        • * Sda
        • * Tma
        • * Lcr
        • * bDNA
        • * Hpa
        • * Nasba
        • * 3SR
        • * Others
          • - Ampliprobe
          • - Car
          • - Cas
          • - Cpt
          • - Dendritic Polymer Technology
          • - Iso-Cr
          • - Lat
          • - Probe Networks
          • - Ramp
          • - Repair Chain Reaction
          • - Rolling Circles
          • - Sequence Independent Gene Amplification
          • - Sequence Initiation Reaction
          • - Sispa
    • C. Detection Technologies
      • 1. Radioactive Methods
        • a. Overview
        • b. Major Isotopes (P-32, S-35, H-3, I-125)
      • 2. Non-Isotopic Methods
        • a. Enzymatic
        • b. Chemical (Indirect, Direct)
        • c. Fluorescence
        • d. Chemiluminescence
        • e. Electrical Conductivity
    • D. Instrumentation Review
      • 2. Autogenomics Infinity
      • 3. Beckman Coulter/Biomek Fk
      • 4. Becton Dickinson Sda
      • 5. Bio-Rad GeneScope
      • 6. Gen-Probe Tigris
      • 7. Nanosphere Verigen Series
      • 8. Roche Cobas Amplicor
      • 9. Tecan Ls Series
    • E. Biochips: Genosensors, Microarrays, and Labs-on-The-Chip
      • - Liquid Transportation and Mixing
      • - Separation
      • - Reaction
      • - Detection
    • F. Pharmacogenomics
    • G. Major Applications
      • 1. Microbiology/Infectious Diseases
        • a. Overview
        • b. Major Infectious Diseases
          • * Aids
          • * Adenovirus
          • * Anthrax/Bacillus Anthracis
          • * Babesiosis
          • * Bea/Bartonella
          • * Chagas Disease
          • * Campylobacter
          • * Chlamydia
          • * Creutzfeldt-Jakob's Disease
          • * Cytomegalovirus
          • * Ebola Virus
          • * EchoVirus
          • * Encephalitis
          • * Enteroviruses
          • * Epstein-Barr Virus
          • * Gonorrhea
          • * Hepatitis A, B, C, D, E, F, G
          • * Herpes Simplex Virus
          • * Legionella
          • * Lyme Disease
          • * Malaria
          • * Mycoplasma
          • * Parvovirus B19
          • * Pneumonia
          • * Polyomaviruses
          • * Salmonellosis
          • * Shigellosis
          • * Streptococci
          • * Toxoplasmosis
          • * Tuberculosis
          • * West Nile Virus
          • * Yersinia
        • c. Antibiotic Susceptibility
      • 2. Cancer Testing
        • a. Overview
        • b. Major Cancer Types
          • * Prostate
          • * Lung
          • * Colon and Rectum
          • * Breast
          • * Skin
          • * Uterine
          • * Leukemia
          • * Oral
        • c. Oncogenes
      • 3. Genetic Diseases
        • a. Overview
        • b. Nucleic Acid Amplification
        • c. Chromosome Imaging
        • d. Genomics Technologies
        • e. Proteomics Technologies
        • f. Current Pharmacogenomic Test
        • g. Future Pharmacogenomic Testing
        • h. Major Diseases
          • * Achondroplasia
          • * Autosomal Dominant Polycystic
          • * Kidney Disease
          • * Cancer
          • * Cosmetogenomics
          • * Cystic Fibrosis
          • * down's Syndrome
          • * Duchenne and Becker
          • * Muscular Dystrophy
          • * Factor V (Leiden)
          • * Factor Ix Deficiency
          • * Fragile X Syndrome
          • * Heart Disease
          • * Hemochomatosis
          • * Hemophilia
          • * Huntington's Disease
          • * Maternal-Fetal Incompatibility
          • * Multiple Endocrine Neoplasia
          • * Phenylketonuria (Pku)
          • * Polycystic Kidney Disease
          • * Prenatal Screening
          • * Retinitis Pigmentosa
          • * Retinoblastoma
          • * Sickle Cell Anemia
          • * Spinal Muscular Atrophy
          • * Vitamin B12 Metabolism
        • I. Social Issues and Concerns
      • 4. Forensic Testing
        • a. Overview
        • b. Multilocus and Single Locus Probes
          • * Multilocus Probes
          • * Single Locus Probes
          • * Pcr and Rflp
        • c. The Fbi
        • d. Dna Profile Data Banks
          • * USA
          • * UK
        • e. Judicial Implementation
        • f. Major Crime Categories
        • g. Factors Contributing to The Dna Probe Market Expansion
          • * Technology Availability
          • * Use of Hair as Evidence
        • h. Wildlife Forensics
      • 5. Paternity Testing/Hla Typing
      • 6. Other Applications
        • a. Disease Susceptibility
        • b. Cardiovascular Diseases
        • c. Diabetes
        • d. Alzheimer's Disease
        • e. Plasma Purification
        • f. Organ Transplantation
        • g. Water Contamination
        • h. Others
    • G. Cost Analysis
      • 1. Equipment
      • 2. Consumables
    • H. Competing/Complementing Technologies
      • 1. Monoclonal Antibodies/Immunoassays
      • 2. Rna Probes
      • 3. 2D Electrophoresis
      • 4. Flow Cytometry
  • I. Reimbursement Issues
    • J. Worldwide Market Overview
      • 1. Business Environment
      • 2. Market Structure
      • 3. Market Size and Growth
  • III. France
    • A. Executive Summary
    • B. Business Environment
    • C. Market Structure
    • D. Market Size, Growth and Major Suppliers' Sales and Market Shares
  • IV. Germany
    • A. Executive Summary
    • B. Business Environment
    • C. Market Structure
    • D. Market Size, Growth and Major Suppliers' Sales and Market Shares
  • V. Italy
    • A. Executive Summary
    • B. Business Environment
    • C. Market Structure
    • D. Market Size, Growth and Major Suppliers' Sales and Market Shares
  • VI. Japan
    • A. Executive Summary
    • B. Business Environment
    • C. Market Structure
    • D. Market Size, Growth and Major Suppliers' Sales and Market Shares
  • VII. Spain
    • A. Executive Summary
    • B. Business Environment
    • C. Market Structure
    • D. Market Size, Growth and Major Suppliers' Sales and Market Shares
  • VIII. UK
    • A. Executive Summary
    • B. Business Environment
    • C. Market Structure
    • D. Market Size, Growth and Major Suppliers' Sales and Market Shares
  • IX. USA
    • A. Executive Summary
    • B. Business Environment
      • 1. Health Care Expenditures
      • 2. Cost Consciousness
      • 3. Reimbursement
      • 4. Industry Consolidation
      • 5. Managed Care
        • a. Hmo
        • b. Ppo
      • 6. Hospitals
      • 7. Admissions
      • 8. Length of Stay
      • 9. Industry Diversification
      • 10. Physician Demographics
      • 11. Population Aging
        • a. Chronic Illness
        • b. Disease Incidence
        • c. Susceptibility to Iatrogenesis
        • d. Multiple Illness Cases
      • 12. Laboratory Regulations
      • 13. FDA Reform
    • C. Market Structure
      • 1. Hospitals
      • 2. Commercial/Private Laboratories
      • 3. Blood Banks
    • D. Market Size, Growth and Major Suppliers' Sales and Market Shares
  • X. Major Product Development Opportunities
    • A. Instrumentation
    • B. Regeant Kits and Test Systems/Panels
    • C. Computers, Software and Automation
    • D. Auxiliary Products
  • XI. Design Criteria for Decentralized Testing Products
  • XII. Alternative Market Penetration Strategies
    • A. Internal Development
    • B. Collaborative Arrangements
    • C. University Contracts
    • D. Distribution Strategies for Decentralized Markets
      • 1. Marketing Approaches
      • 2. Product Complexity
      • 3. Customer Preference
      • 4. Established Suppliers
      • 5. Emerging Suppliers
      • 6. Major Types of Distributors
      • 7. Market Segmentation
  • XIII. Potential Market Entry Barriers and Risks
    • A. Market Maturity
    • B. Cost Containment
    • C. Competition
    • D. Technological Edge and Limitations
    • E. Patent Protection
    • F. Regulatory Constraints
    • G. Decentralized Testing Market Challenges
  • XIV. Competitive Profiles
  • XV. Appendixes
    • Appendix A: Major Companies Developing
      • Or Marketing Molecular Diagnostic Reagents and Test Kits
    • Appendix B: Major Universities and
      • Research Centers Developing Molecular
      • Diagnostic Technology
    • Appendix C: Glossary of Terms
    • Appendix D: Currency Exchange Rates
  • List of Tables
    • Table Ii-1: Major Companies Developing Or Marketing Thermocyclers
    • Table Ii-2: Major Companies Developing Or Marketing Aids Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-3: Major Companies Developing Or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-4: Major Companies Developing Or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-5: Major Companies Developing Or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-6: Major Companies Developing Or Marketing Cmv Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-7: Major Companies Developing Or Marketing Ebv Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-8: Major Companies Developing Or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-9: Major Companies Developing Or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-10: Major Companies Developing Or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-11: Major Companies Developing Or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-12: Major Companies Developing Or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-13: Major Companies Developing Or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-14: Major Companies Developing Or Marketing Papilloma Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-15: Major Companies Developing Or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-16: Major Companies Developing Or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-17: Major Companies Developing Or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-18: Major Companies Developing Or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-19: Major Companies Developing Or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-20: Major Companies Developing Or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
    • Table Ii-21: Major Companies Developing Or Marketing Cancer Molecular Diagnostic Tests
    • Table Ii-22: Major Companies Developing Or Marketing Molecular Diagnostic Tests for Genetic Diseases
    • Table Ii-23: Worldwide, Laboratories Performing Dna Sequencing by Country
    • Table Ii-24: Worldwide, Molecular Diagnostics Market, Potential Laboratory Universe by Country
    • Table Ii-25: Worldwide, Molecular Diagnostic Test Volume Forecast by Country
    • Table Ii-26: Worldwide, Molecular Diagnostics Market Forecast by Country Summary Table: France, Molecular Diagnostic Test Volume and Sales Forecast by Major Application
    • Table Iii-1: France, Laboratories Performing Dna Sequencing by Market Segment
    • Table Iii-2: France, Molecular Diagnostics Market, Potential Laboratory Universe by Segment
    • Table Iii-3: France, Molecular Diagnostic Test Volume Forecast by Major Application
    • Table Iii-4: France, Major Infectious Diseases Molecular Diagnositic Test Volume Forecast by Assay
    • Table Iii-5: France, Infectious Disease Screening Nat Volume Forecast
    • Table Iii-6: France, Molecular Diagnostics Market Forecast by Major Application
    • Table Iii-7: France, Infectious Disease Screening Nat Market Forecast by Test
    • Table Iii-8: France, Molecular Diagnostics Market by Major Supplier
    • Table Iii-9: France, Hiv/Hepatitis Screening Nat Market by Major Supplier Summary Table: Germany, Molecular Diagnostic Test Volume and Sales Forecast by Major Application
    • Table Iv-1: Germany, Laboratories Performing Dna Sequencing by Market Segment
    • Table Iv-2: Germany, Molecular Diagnostics Market, Potential Laboratory Universe by Segment
    • Table Iv-3: Germany, Molecular Diagnostic Test Volume Forecast by Major Application
    • Table Iv-4: Germany, Major Infectious Diseases Molecular Diagnositic Test Volume Forecast by Assay
    • Table Iv-5: Germany, Infectious Disease Screening Nat Volume Forecast
    • Table Iv-6: Germany, Molecular Diagnostics Market Forecast by Major Application
    • Table Iv-7: Germany, Infectious Disease Screening Nat Market Forecast by Test
    • Table Iv-8: Germany, Molecular Diagnostics Market by Major Supplier
    • Table Iv-9: Germany, Hiv/Hepatitis Screening Nat Market by Major Supplier Summary Table: Italy, Molecular Diagnostic Test Volume and Sales Forecast by Major Application
    • Table V-1: Italy, Laboratories Performing Dna Sequencing by Market Segment
    • Table V-2: Italy, Molecular Diagnostics Market, Potential Laboratory Universe by Segment
    • Table V-3: Italy, Molecular Diagnostic Test Volume Forecast by Major Application
    • Table V-4: Italy, Major Infectious Diseases Molecular Diagnostic Test Volume Forecast by Assay
    • Table V-5: Italy, Infectious Disease Screening Nat Volume Forecast
    • Table V-6: Italy, Molecular Diagnostics Market Forecast by Major Application
    • Table V-7: Italy, Infectious Disease Screening Nat Market Forecast by Test
    • Table V-8: Italy, Molecular Diagnostics Market by Major Supplier
    • Table V-9: Italy, Hiv/Hepatitis Screening Nat Market by Major Supplier Summary Table: Japan, Molecular Diagnostic Test Volume and Sales Forecast by Major Application
    • Table Vi-1: Japan, Laboratories Performing Dna Sequencing by Market Segment
    • Table Vi-2: Japan, Molecular Diagnostics Market, Potential Laboratory Universe by Segment
    • Table Vi-3 Japan, Molecular Diagnostic Test Volume Forecast by Major Application
    • Table Vi-4: Japan, Major Infectious Diseases Molecular Diagnositic Test Volume Forecast by Assay
    • Table Vi-5: Japan, Infectious Disease Screening Nat Volume Forecast
    • Table Vi-6: Japan, Molecular Diagnostics Market Forecast by Major Application
    • Table Vi-7: Japan, Infectious Disease Screening Nat Market by Test
    • Table Vi-8: Japan, Molecular Diagnostics Market Forecast by Major Supplier
    • Table Vi-9: Japan, Hiv/Hepatitis Screening Nat Market by Major Supplier Summary Table: Spain, Molecular Diagnostic Test Volume and Sales Forecast by Major Application
    • Table Vii-1: Spain, Laboratories Performing Dna Sequencing by Market Segment
    • Table Vii-2: Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Segment
    • Table Vii-3: Spain, Molecular Diagnostic Test Volume Forecast by Major Application
    • Table Vii-4: Spain, Major Infectious Diseases Molecular Diagnositic Test Volume Forecast by Assay
    • Table Vii-5: Spain, Infectious Disease Screening Nat Volume Forecast
    • Table Vii-6: Spain, Molecular Diagnostics Market Forecast by Major Application
    • Table Vii-7: Spain, Infectious Disease Screening Nat Market by Test
    • Table Vii-8: Spain, Molecular Diagnostics Market by Major Supplier
    • Table Vii-9: Spain, Hiv/Hepatitis Nat Screening Market by Major Supplier Summary Table: UK, Molecular Diagnostic Test Volume and Sales Forecast by Major Application
    • Table Viii-1: UK, Laboratories Performing Dna Sequencing by Market Segment
    • Table Viii-2: UK, Molecular Diagnostics Market, Potential Laboratory Universe by Segment
    • Table Viii-3: UK, Molecular Diagnostic Test Volume Forecast by Major Application
    • Table Viii-4: UK, Major Infectious Diseases Molecular Diagnositic Test Volume Forecast by Assay
    • Table Viii-5: UK, Infectious Disease Screening Nat Volume Forecast
    • Table Viii-6: UK, Molecular Diagnostics Market Forecast by Major Application
    • Table Viii-7: UK, Infectious Disease Screening Nat Market Forecast by Test
    • Table Viii-8: UK, Molecular Diagnostics Market by Major Supplier Summary Table: USA, Molecular Diagnostic Test Volume and Sales Forecast by Major Application
    • Table Ix-1: USA, Laboratories Performing Dna Sequencing by Market Segment
    • Table Ix-2: USA, Molecular Diagnostics Market, Potential Laboratory Universe by Segment
    • Table Ix-3: USA, Molecular Diagnostic Test Volume Forecast by Major Application
    • Table Ix-4: USA, Major Infectious Diseases Molecular Diagnositic Test Volume Forecast by Assay
    • Table Ix-5: USA, Infectious Disease Screening Nat Volume Forecast by Test
    • Table Ix-6: USA, Molecular Diagnostics Market Forecast by Major Application
    • Table Ix-7: USA, Infectious Disease Screening Nat Market Forecast by Test
    • Table Ix-8: USA, Molecular Diagnostics Market by Major Supplier
    • Table Ix-9: USA, Hiv/Hepatitis C Screening Nat Market by Major Supplier
    • Table Ix-10: USA, West Nile Virus Screeing Nat Market by Major Supplier
Back to top

Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

PRINT/CD-ROM:Despatched within 1 to 2 working days.

Actions

© 2010 | Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85

comodo ev ssl site
Internet shopping is safe
SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment